Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Dermatologic Therapy
|
July 9, 2021
Ocular adverse events in patients with atopic dermatitis undergoing treatment with dupilumab: An Italian single-center experience
Maddalena Napolitano, Adriana Di Guida, Gabriella Fabbrocini, et al.
Expert Opinion on Biological Therapy
|
March 26, 2021
The emerging role of dupilumab in dermatological indications
Maddalena Napolitano, Adriana Di Guida, Mariateresa Nocerino, et al.
Minerva Endocrinologica
|
September 24, 2020
Endocrinological disorders and inflammatory skin diseases during COVID-19 outbreak: a review of the literature
Claudio Marasca, Gabriella Fabbrocini, Luigi Barrea, et al.
Skin Appendage Disorders
|
April 2, 2021
Adalimumab in the Management of Isotretinoin-Induced Acne Fulminans: Report of a Case
Claudio Marasca, Gabriella Fabbrocini, Luisa Abategiovanni, et al.
Melanoma Research
|
June 15, 2026
Twenty-one years of cutaneous melanoma: stage shift, anatomical patterns and diagnostic trends from a Southern European tertiary center
Nello Tommasino, Claudia Costa, Alessia Villani, et al.
Dermatologic Therapy
|
September 2, 2021
Dupilumab effectiveness for the treatment of patients with concomitant atopic dermatitis and chronic rhinosinusitis with nasal polyposis
Maddalena Napolitano, Marianna Maffei, Cataldo Patruno, et al.
Medicina (Kaunas, Lithuania)
|
December 23, 2022
Effect of Dupilumab on Sexual Desire in Adult Patients with Moderate to Severe Atopic Dermatitis
Maddalena Napolitano, Gabriella Fabbrocini, Sara Kastl, et al.
Italian Journal of Dermatology and Venereology
|
May 29, 2026
Open-label, uncontrolled clinical investigation of the performance and safety of a foam containing a hyaluronic acid-derived biopolymer and humectants for management of dermatitis in adults
Severino Persechino, Martina Manni, Silvia Innocenti, et al.
Journal of Clinical Medicine
|
March 25, 2022
Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications
Claudio Marasca, Maria Carmela Annunziata, Elisa Camela, et al.
The Journal of Dermatological Treatment
|
April 18, 2022
Drug survival analysis of dupilumab and cyclosporin in patients with atopic dermatitis: a multicenter study
Maddalena Napolitano, Maria Mariano, Antonio Cristaudo, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Dermatologic Therapy
|
July 9, 2021
Ocular adverse events in patients with atopic dermatitis undergoing treatment with dupilumab: An Italian single-center experience
Maddalena Napolitano, Adriana Di Guida, Gabriella Fabbrocini, et al.
Expert Opinion on Biological Therapy
|
March 26, 2021
The emerging role of dupilumab in dermatological indications
Maddalena Napolitano, Adriana Di Guida, Mariateresa Nocerino, et al.
Minerva Endocrinologica
|
September 24, 2020
Endocrinological disorders and inflammatory skin diseases during COVID-19 outbreak: a review of the literature
Claudio Marasca, Gabriella Fabbrocini, Luigi Barrea, et al.
Skin Appendage Disorders
|
April 2, 2021
Adalimumab in the Management of Isotretinoin-Induced Acne Fulminans: Report of a Case
Claudio Marasca, Gabriella Fabbrocini, Luisa Abategiovanni, et al.
Melanoma Research
|
June 15, 2026
Twenty-one years of cutaneous melanoma: stage shift, anatomical patterns and diagnostic trends from a Southern European tertiary center
Nello Tommasino, Claudia Costa, Alessia Villani, et al.
Dermatologic Therapy
|
September 2, 2021
Dupilumab effectiveness for the treatment of patients with concomitant atopic dermatitis and chronic rhinosinusitis with nasal polyposis
Maddalena Napolitano, Marianna Maffei, Cataldo Patruno, et al.
Medicina (Kaunas, Lithuania)
|
December 23, 2022
Effect of Dupilumab on Sexual Desire in Adult Patients with Moderate to Severe Atopic Dermatitis
Maddalena Napolitano, Gabriella Fabbrocini, Sara Kastl, et al.
Italian Journal of Dermatology and Venereology
|
May 29, 2026
Open-label, uncontrolled clinical investigation of the performance and safety of a foam containing a hyaluronic acid-derived biopolymer and humectants for management of dermatitis in adults
Severino Persechino, Martina Manni, Silvia Innocenti, et al.
Journal of Clinical Medicine
|
March 25, 2022
Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications
Claudio Marasca, Maria Carmela Annunziata, Elisa Camela, et al.
The Journal of Dermatological Treatment
|
April 18, 2022
Drug survival analysis of dupilumab and cyclosporin in patients with atopic dermatitis: a multicenter study
Maddalena Napolitano, Maria Mariano, Antonio Cristaudo, et al.
Page
of 2